Viridian Therapeutics Inc (NASDAQ:VRDN)
| 22.60 Delayed Data As of 3:59pm ET |  -0.21 / -0.92%Today’s Change | 9.47 Today|||52-Week Range 26.22 | +14.31% Year-to-Date |
Latest VRDN News | Press Releases
| Wall Street Analysts Predict an 89% Upside in Viridian Therapeutics, Inc. (VRDN): Here's What You Should Know Nov 17 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 22.81 |
| Today’s open | 23.13 |
| Day’s range | 22.32 - 23.25 |
| Volume | 9,807 |
| Average volume (3 months) | 680,606 |
| Market cap | $923.3M |
Data as of 3:59pm ET, 11/28/2022
Growth & Valuation
| Earnings growth (last year) | +78.59% |
| Earnings growth (this year) | +46.29% |
| Earnings growth (next 5 years) | +7.59% |
| Revenue growth (last year) | +182.19% |
| P/E ratio | NM |
| Price/Sales | 79.53 |
| Price/Book | 10.19 |
Competitors
Data as of 4:00pm ET, 11/28/2022
Financials
| Next reporting date | March 15, 2023 |
| EPS forecast (this quarter) | -$0.75 |
| Annual revenue (last year) | $3.0M |
| Annual profit (last year) | -$79.4M |
| Net profit margin | -2,680.16% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
